Astrana Health (NASDAQ:ASTH – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37), Zacks reports. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%.
Astrana Health Price Performance
Shares of NASDAQ:ASTH traded down $0.42 during midday trading on Thursday, reaching $34.68. 235,435 shares of the company’s stock traded hands, compared to its average volume of 335,343. The company has a market cap of $1.95 billion, a P/E ratio of 26.68, a PEG ratio of 1.37 and a beta of 1.20. The company has a fifty day simple moving average of $35.01 and a two-hundred day simple moving average of $44.72. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health has a 1 year low of $29.08 and a 1 year high of $63.20.
Analyst Ratings Changes
Several equities research analysts have commented on the company. Robert W. Baird boosted their target price on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Macquarie upgraded Astrana Health to a “hold” rating in a research note on Monday, December 16th. Stifel Nicolaus dropped their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Finally, Truist Financial lowered their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Two analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and an average target price of $65.60.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
- Five stocks we like better than Astrana Health
- What Makes a Stock a Good Dividend Stock?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How to Invest in Biotech Stocks
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What Is WallStreetBets and What Stocks Are They Targeting?
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.